Attention Deficit/Hyperactivity Disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meet criteria for DSM-5 Attention Deficit/Hyperactivity Disorder (ADHD); 2. Male and female patients of age 6-16 years with normal eyesight; 3. WISC-CR?70; 4. In a stable condition, capable of participating in the assessment of cognitive function; 5. Didn't receive medical treatment of stimulants, antiepileptic drugs, benzodiazepines or other psychotic medications in the last 2 weeks; 6. Capable of cooperating with investigators in assessments; 7. Consent of patient and his/her parents.
Exclusion criteria
Exclusion criteria: 1) Severe physical diseases, Angle-closure glaucoma, history of epilepsy; 2) Agoraphobia, or severe anxiety/fear for enclosed space; 3) Comorbidity with mental retardation, autism spectrum disorder or other developmental disorders; 4) Comorbidity with schizophrenia, bipolar affective disorder or other severe mental diseases; 5) Previously treated with atomoxetine but appeared ineffective, or had severe adverse events; 6) Patients considered not eligible for the trials by investigators.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Parent Symptom Questionnaire, PSQ;(Strengths and Difficulties Questionnaire, SDQ;Behavior Rating Inventory of Executive Function, BRIEF;ADHD Knowing Questionnaire;Treatment Emergent Symptom Scale, TESS; | — |
Primary
| Measure | Time frame |
|---|---|
| Swanson, Nolan and Pelham Teacher and Parent Rating Scale,SNAP-IV; | — |
Countries
China
Contacts
Beijing Anding Hospital Capital Medical University